Cancer patients in Lebanon face treatment delays and financial barriers as the country’s economic crisis strains the healthcare system, according to a multicenter cross-sectional study published in Cureus. Over half of the study participants experienced delays in initiating care, driven heavily by mounting costs, administrative hurdles, and administrative approval bottlenecks.
Demographic and Financial Strain Among Lebanese Cancer Patients
The descriptive multicenter cross-sectional study analyzed 244 cancer patients to evaluate the intersection of economic hardship and oncology care delivery. According to the findings, 144 participants were female (59.0%) and 100 were male (41.0%), with the majority aged 60 years or older (n = 147; 60.2%). Over half of the cohort, or 57.0% (n = 139), reported lacking medical insurance entirely, forcing patients to navigate high out-of-pocket expenses amid a collapsing national economy.
Financial distress emerged as a pervasive factor for nearly all respondents. A decrease in household income since the onset of Lebanon’s economic crisis was reported by 215 participants (88.1%), while only 29 individuals (11.9%) stated their income remained unaffected. Furthermore, 96 participants (39.3%) relied on unfixed income sources such as informal work, personal loans, debts, or charitable donations.
Advanced Disease Stages and Treatment Delays
Clinical characteristics revealed a heavy burden of late-stage diagnoses within the study population. More than half of the patients presented with stage IV disease (n = 123; 50.4%), followed by stage III disease at 22.1% (n = 54). Breast cancer was the most common diagnosis at 27.0% (n = 66), followed by colorectal cancer at 15.2% (n = 37) and lung cancer at 14.7% (n = 36).
Overall, 128 patients (52.5%) experienced a delay in treatment initiation ranging from more than two weeks to more than 12 weeks following their initial cancer diagnosis. Among those facing delays, the primary contributing factors included pre-treatment surgery (46.1%), delayed imaging reports (28.1%), direct financial constraints (27.3%), and delayed laboratory results (25.8%). Administrative roadblocks also played a role, with 11.7% of delayed patients citing slow guarantor approvals from third-party payers or the Ministry of Public Health.
Private Sector Insurance Costs and Long-Term Trends
Complementing the acute care barriers identified in hospital settings, longitudinal data from Lebanon’s private insurance sector highlight the massive fiscal scale of oncology care. A retrospective cohort analysis published in Frontiers in Medicine examined insurance claims from a leading Lebanese third-party administrator between 2018 and 2024. The data tracked 16,617 unique cancer patients who generated 157,550 claims totaling $239.9 million in expenditures over the seven-year period.
The private sector data showed that annual expenditures rose from $35.7 million in 2018 to $48.9 million in 2024, despite a temporary dip during the height of the financial contraction. While surgical procedures accounted for the largest share of patient treatment volume at 29.3%, cancer medications drove the highest financial costs, representing 37.8% of total spending. A small high-cost cohort comprising 285 patients (1.7%) accounted for $55.1 million—or 23.0%—of cumulative expenditures, demonstrating how advanced systemic therapies concentrate financial risk within private health portfolios.
Frequently Asked Questions
What are the primary causes of cancer treatment delays in Lebanon?
According to the Cureus study, treatment delays stem primarily from required pre-treatment surgeries, delayed imaging and laboratory results, direct financial constraints, and administrative bottlenecks involving guarantor approvals from insurance providers or the Ministry of Public Health.
How has the economic crisis affected household finances for cancer patients?
The research indicates that 88.1% of surveyed cancer patients experienced a reduction in household income since the economic crisis began, with nearly 40% relying on unstable income sources like informal labor, loans, or donations.
What percentage of patients in the study lacked medical insurance?
Data from the multicenter study show that 57.0% of participating cancer patients did not have medical insurance coverage, leaving them vulnerable to the direct costs of oncology care.
Keep reading